Non-Current Assets
Long-term marketable securities
Humana Long-term marketable securities increased by 27.0% to $626.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 52.7%, from $410.00M to $626.00M. Over 4 years (FY 2021 to FY 2025), Long-term marketable securities shows a downward trend with a -10.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026
How to read this metric
An increase indicates a long-term capital preservation strategy, while a decrease suggests the liquidation of long-term investments to fund operations or debt repayment.
Detailed definition
This represents long-term investments in debt securities that the company intends to hold for more than one year. These...
Peer comparison
Used by mature companies with strong cash flows to manage long-term liquidity and investment returns.
Metric ID:
non_current_assets_available_for_sale_securities_debt_se_908f76Historical Data
14 periods
| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $780.00M | $380.00M | $371.00M | $389.00M | $382.00M | $380.00M | $388.00M | $400.00M | $421.00M | $410.00M | $431.00M | $440.00M | $493.00M | $626.00M |
| QoQ Change | — | -51.3% | -2.4% | +4.9% | -1.8% | -0.5% | +2.1% | +3.1% | +5.3% | -2.6% | +5.1% | +2.1% | +12.0% | +27.0% |
| YoY Change | — | -51.3% | — | — | +0.5% | +2.4% | -0.3% | — | +10.2% | +7.9% | +11.1% | +10.0% | +17.1% | +52.7% |
Range$371.00M – $780.00M
CAGR-6.5%
Avg YoY Growth+6.0%
Median YoY Growth+8.9%
Current Streak4 quarters growth
Long-term marketable securities at Other Companies
Frequently Asked Questions
- What is Humana's long-term marketable securities?
- Humana (HUM) reported long-term marketable securities of $626.00M in Q1 2026.
- How has Humana's long-term marketable securities changed year-over-year?
- Humana's long-term marketable securities increased by 52.7% year-over-year, from $410.00M to $626.00M.
- What is the long-term trend for Humana's long-term marketable securities?
- Over 4 years (2021 to 2025), Humana's long-term marketable securities has grown at a -10.8% compound annual growth rate (CAGR), from $780.00M to $493.00M.
- What does long-term marketable securities mean?
- Long-term investments in debt securities held for interest income.